BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31611342)

  • 21. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
    Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
    J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.
    Bai XJ; Liang Y; Yang YR; Feng JD; Luo ZP; Zhang JX; Wu XQ
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():8-13. PubMed ID: 26851588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
    Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
    Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
    Penn-Nicholson A; Hraha T; Thompson EG; Sterling D; Mbandi SK; Wall KM; Fisher M; Suliman S; Shankar S; Hanekom WA; Janjic N; Hatherill M; Kaufmann SHE; Sutherland J; Walzl G; De Groote MA; Ochsner U; Zak DE; Scriba TJ;
    PLoS Med; 2019 Apr; 16(4):e1002781. PubMed ID: 30990820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
    Della Bella C; Spinicci M; Grassi A; Bartalesi F; Benagiano M; Truthmann K; Tapinassi S; Troilo A; D'Elios S; Alnwaisri H; Shuralev E; Singh M; Bartoloni A; D'Elios MM
    PLoS One; 2018; 13(6):e0197825. PubMed ID: 29856871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of Serum Biomarkers for Distinguishing between Latent and Active Tuberculosis Using Proteome Microarray.
    Cao SH; Chen YQ; Sun Y; Liu Y; Zheng SH; Zhang ZG; Li CY
    Biomed Environ Sci; 2018 Jul; 31(7):515-526. PubMed ID: 30145986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.
    Pourakbari B; Mamishi S; Marjani M; Rasulinejad M; Mariotti S; Mahmoudi S
    Mol Diagn Ther; 2015 Oct; 19(5):309-16. PubMed ID: 26245995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.
    Santin M; Morandeira-Rego F; Alcaide F; Rabuñal R; Anibarro L; Agüero-Balbín R; Casas-Garcia X; Pérez-Escolano E; Navarro MD; Sánchez F; Coira-Nieto A; Trigo-Daporta M; Martinez-Meñaca A; Gonzalez-Cuevas A; López-Prieto MD; Domínguez-Castellano A; Jové N;
    Clin Microbiol Infect; 2016 Dec; 22(12):1007.e1-1007.e5. PubMed ID: 27647563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB.
    Wang S; Li Y; Shen Y; Wu J; Gao Y; Zhang S; Shao L; Jin J; Zhang Y; Zhang W
    J Transl Med; 2018 Jul; 16(1):206. PubMed ID: 30029650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity.
    Kumar NP; Banurekha VV; Nair D; Dolla C; Kumaran P; Babu S
    Tuberculosis (Edinb); 2018 Jan; 108():127-135. PubMed ID: 29523313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and disease.
    Guggino G; Orlando V; Cutrera S; La Manna MP; Di Liberto D; Vanini V; Petruccioli E; Dieli F; Goletti D; Caccamo N
    Immunol Lett; 2015 Aug; 166(2):87-91. PubMed ID: 26051682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
    Davidow AL
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis.
    Petruccioli E; Petrone L; Vanini V; Cuzzi G; Navarra A; Gualano G; Palmieri F; Girardi E; Goletti D
    J Infect; 2015 Nov; 71(5):526-33. PubMed ID: 26253021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of interferon-γ-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis.
    Qiu X; Tang Y; Yue Y; Zeng Y; Li W; Qu Y; Mu D
    Clin Microbiol Infect; 2019 Jun; 25(6):667-672. PubMed ID: 30553864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of heat shock proteins for discriminating between latent tuberculosis infection and active tuberculosis: A preliminary report.
    Shekhawat SD; Purohit HJ; Taori GM; Daginawala HF; Kashyap RS
    J Infect Public Health; 2016; 9(2):143-52. PubMed ID: 26300163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.